Grant: Project Grant
McMaster University
$1,682,998.00
Dial-Bicarb Trial: Lower vs. Higher Dialysate Bicarbonate Concentration in Patients Receiving Hemodialysis
EF 2022-23
Résumé
We are planning to conduct a trial that will compare different concentrations of bicarbonate in the dialysis solution. The bicarbonate concentrations compared in this trial will fall in the range of what is already used in the Canadian hemodialysis centres. There is some early evidence to suggest that a higher concentration of bicarbonate in the dialysis solution may increase the risk of death and hospitalization.
We will use a new, streamlined approach to do this large trial, which will be done in more than 140 Canadian hemodialysis centres (which during the 4-year trial period will care for more than 20,000 patients and provide over 12 million dialysis treatments). The streamlined approach includes analyzing information already collected in routine care that is stored in large healthcare databases.
If we can show that a lower concentration of bicarbonate in the dialysis solution reduces the risk of death and hospitalization and overall improves patient health, then it could become the standard of care for all patients worldwide. This simple adjustment to the dialysis procedure can be done at no added cost and may even help to reduce healthcare costs.
Programme
Project Grant
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
478853
Name
Molnar Amber
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Clinical
Prcname2
Randomized Controlled Trials
Projecttitle
Dial-Bicarb Trial: Lower vs. Higher Dialysate Bicarbonate Concentration in Patients Receiving Hemodialysis
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$1,682,998
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Dialysis; Kidney Disease; Kidney Failure
Abstract
We are planning to conduct a trial that will compare different concentrations of bicarbonate in the dialysis solution. The bicarbonate concentrations compared in this trial will fall in the range of what is already used in the Canadian hemodialysis centres. There is some early evidence to suggest that a higher concentration of bicarbonate in the dialysis solution may increase the risk of death and hospitalization.
We will use a new, streamlined approach to do this large trial, which will be done in more than 140 Canadian hemodialysis centres (which during the 4-year trial period will care for more than 20,000 patients and provide over 12 million dialysis treatments). The streamlined approach includes analyzing information already collected in routine care that is stored in large healthcare databases.
If we can show that a lower concentration of bicarbonate in the dialysis solution reduces the risk of death and hospitalization and overall improves patient health, then it could become the standard of care for all patients worldwide. This simple adjustment to the dialysis procedure can be done at no added cost and may even help to reduce healthcare costs.
Competitiondate
202303
Approvedterm2
6 yrs 0 mth
Pinamesdelim
Molnar, Amber; Garg, Amit; Harris, Claire; Silver, Samuel; Tennankore, Karthik K
Approvedterm
6 ans 0 mois
Cihrcontribution2
~ $1,682,998~ $0~